![]() |
Name |
1,1,3,3,5,5,7,7,9,9,11,11-Dodecamethylhexasiloxane
|
Molecular Formula | C12H36O5Si6 | |
IUPAC Name* |
NA
|
|
SMILES |
C[Si](C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)C
|
|
InChI |
InChI=1S/C12H36O5Si6/c1-18(2)13-20(5,6)15-22(9,10)17-23(11,12)16-21(7,8)14-19(3)4/h1-12H3
|
|
InChIKey |
MEJKNMVFSMYBHE-UHFFFAOYSA-N
|
|
Synonyms |
1,1,3,3,5,5,7,7,9,9,11,11-Dodecamethylhexasiloxane; 995-82-4; Hexasiloxane, 1,1,3,3,5,5,7,7,9,9,11,11-dodecamethyl-; 2,4,4,6,6,8,8,10,10,12-decamethyl-3,5,7,9,11-pentaoxa-2,4,6,8,10,12-hexasilatridecane; SCHEMBL3695635; DTXSID80880645; AMY42192; MFCD00513634; AKOS037646545; AS-69467; D4570; 1,1,3,3,5,5,7,7,9,9,11,11-Dodecamethylhexasiloxane #
|
|
CAS | 995-82-4 | |
PubChem CID | 6329090 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 428.92 | ALogp: | 4.4 |
HBD: | 0 | HBA: | 5 |
Rotatable Bonds: | 10 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 46.2 | Aromatic Rings: | 0 |
Heavy Atoms: | 23 | QED Weighted: | 0.463 |
Caco-2 Permeability: | -5.639 | MDCK Permeability: | 0.00005000 |
Pgp-inhibitor: | 0.15 | Pgp-substrate: | 0.313 |
Human Intestinal Absorption (HIA): | 0.978 | 20% Bioavailability (F20%): | 0.012 |
30% Bioavailability (F30%): | 0.01 |
Blood-Brain-Barrier Penetration (BBB): | 0 | Plasma Protein Binding (PPB): | 106.98% |
Volume Distribution (VD): | 3.049 | Fu: | 13.59% |
CYP1A2-inhibitor: | 0.292 | CYP1A2-substrate: | 0.97 |
CYP2C19-inhibitor: | 0.843 | CYP2C19-substrate: | 0.965 |
CYP2C9-inhibitor: | 0.803 | CYP2C9-substrate: | 0.952 |
CYP2D6-inhibitor: | 0.066 | CYP2D6-substrate: | 0.929 |
CYP3A4-inhibitor: | 0.395 | CYP3A4-substrate: | 0.11 |
Clearance (CL): | 2.496 | Half-life (T1/2): | 0.442 |
hERG Blockers: | 0.394 | Human Hepatotoxicity (H-HT): | 0.007 |
Drug-inuced Liver Injury (DILI): | 0.018 | AMES Toxicity: | 0.033 |
Rat Oral Acute Toxicity: | 0 | Maximum Recommended Daily Dose: | 0.172 |
Skin Sensitization: | 0.658 | Carcinogencity: | 0.028 |
Eye Corrosion: | 1 | Eye Irritation: | 0.997 |
Respiratory Toxicity: | 0.046 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001784 | ![]() |
0.851 | D0Z1ZM | ![]() |
0.090 | ||
ENC001783 | ![]() |
0.740 | D0H2DQ | ![]() |
0.090 | ||
ENC000373 | ![]() |
0.471 | D06IGU | ![]() |
0.089 | ||
ENC000530 | ![]() |
0.403 | D06ZUP | ![]() |
0.087 | ||
ENC003080 | ![]() |
0.341 | D0L2UN | ![]() |
0.086 | ||
ENC001271 | ![]() |
0.308 | D02YIZ | ![]() |
0.086 | ||
ENC001404 | ![]() |
0.277 | D04JMQ | ![]() |
0.085 | ||
ENC001122 | ![]() |
0.261 | D07DIM | ![]() |
0.084 | ||
ENC003081 | ![]() |
0.258 | D03HJK | ![]() |
0.084 | ||
ENC001182 | ![]() |
0.258 | D06EEL | ![]() |
0.083 |